Castleark Management’s Surgery Partners SGRY Stock Holding History

Castleark Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-116,020	Closed	-$3.39M	–	308
2023 Q3	$3.39M	Sell	116,020 -24,970	-18%	-$898K	0.17%	134
2023 Q2	$6.34M	Buy	+140,990	New	+$5.38M	0.29%	74
2022 Q3	–	Sell	-123,628	Closed	-$3.58M	–	327
2022 Q2	$3.58M	Sell	123,628 -2,585	-2%	-$113K	0.19%	121
2022 Q1	$6.95M	Buy	126,213 +34,460	+38%	+$1.7M	0.3%	80
2021 Q4	$4.9M	Sell	91,753 -76,040	-45%	-$3.53M	0.18%	132
2021 Q3	$7.1M	Sell	167,793 -7,020	-4%	-$358K	0.27%	100
2021 Q2	$11.6M	Sell	174,813 -157,246	-47%	-$8.54M	0.39%	61
2021 Q1	$14.7M	Buy	332,059 +61,638	+23%	+$2.29M	0.53%	41
2020 Q4	$7.84M	Buy	270,421 +16,381	+6%	+$408K	0.29%	90
2020 Q3	$5.56M	Buy	+254,040	New	+$4.52M	0.22%	118

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Castleark Management's SGRY Position: Q4 2023 in Review

Castleark Management sold out of Surgery Partners (SGRY) in Q4 2023, closing a stake of 116,020 shares — an estimated $3.39M sold.

Castleark Management first reported a position in SGRY in Q3 2020 and held it in 10 quarters. The position peaked at $14.7M in Q1 2021. 174 funds tracked by Wall St. Rank hold SGRY as of Q4 2023.

Castleark Management reported no remaining Surgery Partners position as of Q4 2023 after selling out during the quarter.
Castleark Management sold 116,020 Surgery Partners shares in Q4 2023, an estimated $3.39M.
Castleark Management first reported a position in Surgery Partners in Q3 2020 and held it in 10 quarters.
Castleark Management's Surgery Partners position peaked at $14.7M in Q1 2021.
174 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2023.

Based on Castleark Management's 13F filing for Q4 2023, filed 15 Feb 2024.